367 related articles for article (PubMed ID: 16967494)
1. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates.
Wang L; Abbasi F; Gaigalas AK; Hoffman RA; Flagler D; Marti GE
Cytometry B Clin Cytom; 2007 Nov; 72(6):442-9. PubMed ID: 17474131
[TBL] [Abstract][Full Text] [Related]
3. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
[TBL] [Abstract][Full Text] [Related]
4. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
5. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
[TBL] [Abstract][Full Text] [Related]
9. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
Fortin M; Hugo P
Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
[TBL] [Abstract][Full Text] [Related]
10. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry.
Islam D; Lindberg AA; Christensson B
Cytometry; 1995 Jun; 22(2):128-34. PubMed ID: 7587743
[TBL] [Abstract][Full Text] [Related]
12. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
13. Instrument-dependent fluorochrome sensitivity in flow cytometric analyses.
Chance JT; Larsen SA; Pope V; Measel JW; Cox DL
Cytometry; 1995 Sep; 22(3):232-42. PubMed ID: 8556955
[TBL] [Abstract][Full Text] [Related]
14. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
Gupta R; Jain P; Deo SV; Sharma A
Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
[TBL] [Abstract][Full Text] [Related]
16. A standardized ZAP-70 assay--lessons learned in the trenches.
Shults KE; Miller DT; Davis BH; Flye L; Hobbs LA; Stelzer GT
Cytometry B Clin Cytom; 2006 Jul; 70(4):276-83. PubMed ID: 16906586
[TBL] [Abstract][Full Text] [Related]
17. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
[TBL] [Abstract][Full Text] [Related]
18. Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma.
Horvat M; Kloboves Prevodnik V; Lavrencak J; Jezersek Novakovic B
Oncol Rep; 2010 Oct; 24(4):1101-7. PubMed ID: 20811695
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
[TBL] [Abstract][Full Text] [Related]
20. Isotype controls in phenotyping and quantification of microparticles: a major source of error and how to evade it.
Trummer A; De Rop C; Tiede A; Ganser A; Eisert R
Thromb Res; 2008; 122(5):691-700. PubMed ID: 18304614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
